Active Chemical Molecule
Gefitinib
Gefitinib
Classification: Anticancer Medicine
Gefitinib?
It is a targeted anticancer medicine used against lung cancer.
Uses
- • Non-small cell lung cancer
- • Previously treated lung cancer
- • Advanced lung cancer
- • Head and neck cancer (off-label)
Working of Gefitinib
- • Inhibits cancer cell protein
- • Stops cancer cell growth and proliferation
- • Shrinks the tumor size
Common Side Effects
- • Diarrhea
- • Reduced hunger
- • Nausea
- • Vomiting
- • Liver dysfunction
- • Skin rashes
- • Redness of the eyes
- • Tiredness
Serious Side Effects
- • Skin peeling, severe rashes
- • Inflammation of the lungs
- • Eye damage
- • Jaundice
- • Liver toxicity
- • Shortness of breath
Precautions
To be used cautiously in:
- • Liver disorder
- • Respiratory disorders
- • Lung disorders
- • Kidney disorders
- • Eye disorders
- • Avoid certain medications: Rifampin, phenytoin, and antacids
Contraindications
- • Hypersensitivity to the drug compound
- • Breastfeeding mothers
- • Pregnant women
Important Safety and Monitoring Note
Monitor:
- • Liver functions
- • Skin issues
- • Breathing difficulties
- • Changes in vision or redness
- • Use contraception before and during treatment
Warnings
To be used under a doctor's supervision.
Gandhi Medicos – Global Supplier of Certified Anticancer Medicines
Gandhi Medicos stands as one of the world’s largest and most trusted exporters of premium-quality anticancer medicines, reaching over 50 countries with commitment and care.
Why Gandhi Medicos?
- • Original & Authentic Medicines
- • Trusted by Leading Hospitals and Oncologists
- • 25,000+ Satisfied Customers Worldwide
- • WHO–GMP Certified Products
- • 300+ Branded & 400+ Generic Oncology Products
- • Temperature-Controlled Logistics
- • Expert Customer Support for Product Guidance
- • Traceable shipments and timely delivery
Trusted medicines, timely access, and uncompromised integrity
Formulations based on "Gefitinib" (1)

Anti Cancer DrugsVerified Supply
Geftinat 250mg
Gefitinib
Geftinat 250 mg (Gefitinib) is specified against a type of lung cancer (non-small cell) wherein cells are mutated in epidermal growth factor receptor (EGFR). EGFR is expressed on the cell surface o...
Specialty BrandNatco
Unit Dosage (250 mg)
Clinical SourceAprazer Healthcare
Temp Tracked: Store below 30°C
